Founded by Dr. Andrew Hopkinson and co-owned by Professor Harminder Dua, NuVision™ harnesses the regenerative properties of amniotic tissue to improve recovery from front of the eye disease, surgical and other traumatic injuries. The company's ophthalmic therapies aim to address key clinical challenges facing ophthalmic surgeons, with a focus on developing innovative, high-quality, and cost-effective regenerative therapies for ophthalmology and wound care.